April 6, 2018 / 1:44 PM / 6 months ago

BUZZ-EyeGate Pharmaceuticals: Soars on milestone payment from Valeant

** Eye drug developer’s shares up 74.3 pct at $0.68 on receiving milestone payment from Valeant Pharma

** Stock on pace for its best day in over a year

** EYEG gets milestone payment from VRX on completing patient enrollment for mid-stage study of EGP-437 to treat non-infectious anterior uveitis

** Anterior uveitis is an inflammation of middle layer of the eye

** In 2015, companies entered deal through which EYEG gave Valeant rights to its EyeGate II Delivery System and EGP-437 combination product in the field of uveitis

** Over 1.8 mln shares traded, ~9x their 30-DMA

** Including today’s gains, EYEG has declined 38 pct this year (Reporting by Amy Caren Daniel in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below